Related Experiment Video
Updated: May 27, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
System Dynamics Modeling for Diabetes Treatment and Prevention Planning
Areez Hirani1, Aziz Guergachi1,2,3, Karim Keshavjee1,2
1Ted Rogers School of Management, Toronto Metropolitan University, Toronto, Canada.
New AI tools and treatments may increase Type 2 Diabetes (T2D) prevalence and costs. Combining these innovations with preventive strategies is crucial for managing chronic disease and healthcare spending effectively.
Area of Science:
- Health economics
- Population health management
- Computational modeling
Background:
- Rising rates of preventable chronic diseases, like Type 2 Diabetes (T2D), strain Canadian healthcare budgets and individual finances.
- Emerging AI-driven predictive tools and life-prolonging treatments necessitate evaluation of their impact on population health and healthcare expenditures.
Purpose of the Study:
- To analyze the long-term effects of AI predictive tools, novel treatments, and digital behavior change applications on T2D prevalence and healthcare costs using system dynamics modeling.
- To forecast the secondary effects of healthcare policy decisions on chronic disease management and costs.
Main Methods:
- System dynamics modeling was employed to simulate three distinct scenarios over a 50-year timeframe.
- The model assessed the interplay between technological innovations, treatment interventions, and preventive measures on T2D incidence and healthcare spending.
Main Results:
- AI and novel treatments may reduce T2D complications but could paradoxically increase T2D prevalence and overall healthcare expenditures.
- Preventive measures are essential to counteract potential cost increases and manage T2D prevalence when implementing new health technologies.
Conclusions:
- System dynamics models are valuable for forecasting the complex, long-term consequences of healthcare innovations and policy choices.
- Effective management of the evolving chronic disease landscape requires integrated strategies that combine advanced treatments with robust preventive measures.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications

